Skip to content

Drug interactions

Cenobamate + Dexamethasone-neomycin-polymyxin

Severity: Minor

Cenobamate and Dexamethasone-neomycin-polymyxin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cenobamate is a CYP3A4 inducer and may reduce dexamethasone exposure. With topical or ophthalmic dexamethasone the systemic impact is small, but local efficacy is unlikely to change.

What this interaction means in plain words

Cenobamate and Dexamethasone-neomycin-polymyxin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Cenobamate belongs to Central Nervous System; Dexamethasone-neomycin-polymyxin belongs to Anti Bacterial.

Evidence level: Low

Why it happens

Cenobamate induces CYP3A4, accelerating dexamethasone metabolism.

What to do

No adjustment is routinely needed for topical use; if the therapeutic response is lacking, reassess the dose or treatment.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cenobamate and Dexamethasone-neomycin-polymyxin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cenobamate with Dexamethasone-neomycin-polymyxin?

MediHelp rates the interaction as minor. Cenobamate and Dexamethasone-neomycin-polymyxin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Cenobamate is a CYP3A4 inducer and may reduce dexamethasone exposure. With topical or ophthalmic dexamethasone the systemic impact is small, but local efficacy is unlikely to change.

How serious is the interaction between Cenobamate and Dexamethasone-neomycin-polymyxin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No adjustment is routinely needed for topical use; if the therapeutic response is lacking, reassess the dose or treatment.

What other medicines interact with Dexamethasone-neomycin-polymyxin?

MediHelp also lists interactions of Dexamethasone-neomycin-polymyxin with, for example, Ketorolac, Lapatinib, Levofloxacin. The full list is on the Dexamethasone-neomycin-polymyxin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in